Nigg Joel T, Johnstone Jeanette M, Musser Erica D, Long Hilary Galloway, Willoughby Michael T, Shannon Jackilen
Oregon Health & Science University, Portland, OR, United States.
Oregon Health & Science University, Portland, OR, United States.
Clin Psychol Rev. 2016 Feb;43:67-79. doi: 10.1016/j.cpr.2015.11.005. Epub 2015 Dec 2.
Literature has suggested that ADHD may be associated with increased risk of obesity. If so, this would have important clinical implications.
To clarify the size of the association between ADHD and obesity and to evaluate key moderators of the association including medication, gender, age, and psychiatric comorbidity.
Two preliminary studies are presented to supply critical additional data for the meta-analysis: a two-year longitudinal study of an ADHD case-control sample of 313 children aged 7-11, and a national survey study of 45,309 families in the United States using the 2012 National Survey of Children's Health. Formal meta-analysis was then conducted. The identification procedure yielded 43 studies, reporting 225 comparisons or effect sizes, studying 703,937 participants An overall effect size was estimated with a random effects model (after pooling within study using a modified fixed effects model). Effect size was then examined in relation to medication, gender, age, and psychiatric comorbidity.
The new study of children revealed no reliable association of ADHD and body mass index at any age or time point. In the national survey, ADHD was associated with obesity only in adolescent girls but not in children or boys; this effect was statistically accounted for by covarying of depression and conduct disorder. In the meta-analysis, the composite effect size was OR=1.22 (95% CI=1.11-1.34); 22 studies provided effects with medication controlled, yielding a composite effect size of OR=1.30 (95% CI=1.12-1.50). Pooled across age the association without covariates was reliable in females (OR=1.19 [1.01-1.41]) but not males (OR=1.10 [0.95-1.23]) although males and females did not statistically differ. Pooled across gender, the association was significantly larger in adults (>18years) (OR=1.37 [1.19-1.58]) than in youth (OR=1.13 [1.00-1.27]), p=.04.
ADHD has a small overall association with obesity, but this effect is moderate in adults. The effect is likely to be of no clinical significance in children, possible clinical significance in adolescent girls with comorbid disorders, and of clinical relevance by adulthood.
文献表明注意力缺陷多动障碍(ADHD)可能与肥胖风险增加有关。如果是这样,这将具有重要的临床意义。
明确ADHD与肥胖之间关联的程度,并评估该关联的关键调节因素,包括药物治疗、性别、年龄和精神共病。
呈现两项初步研究以提供荟萃分析所需的关键补充数据:一项对313名7至11岁ADHD病例对照样本儿童进行的为期两年的纵向研究,以及一项使用2012年美国儿童健康全国调查对45309个美国家庭进行的全国性调查研究。然后进行正式的荟萃分析。识别程序产生了43项研究,报告了225项比较或效应量,涉及703937名参与者。使用随机效应模型估计总体效应量(在使用改良固定效应模型在研究内合并后)。然后检查效应量与药物治疗、性别、年龄和精神共病的关系。
对儿童的新研究表明,在任何年龄或时间点,ADHD与体重指数之间均无可靠关联。在全国性调查中,ADHD仅与青春期女孩的肥胖有关,而与儿童或男孩无关;这种效应在统计学上可通过抑郁和品行障碍的协变量来解释。在荟萃分析中,综合效应量为OR = 1.22(95%CI = 1.11 - 1.34);22项研究提供了药物控制后的效应量,综合效应量为OR = 1.30(95%CI = 1.12 - 1.50)。按年龄汇总,无协变量时女性的关联可靠(OR = 1.19 [1.01 - 1.41]),男性不可靠(OR = 1.10 [0.95 - 1.23]),尽管男性和女性在统计学上无差异。按性别汇总,成年人(>18岁)的关联(OR = 1.37 [1.19 - 1.58])显著大于青少年(OR = 1.13 [1.00 - 1.27]),p = 0.04。
ADHD与肥胖总体关联较小,但在成年人中这种效应中等。该效应在儿童中可能无临床意义,在患有共病的青春期女孩中可能有临床意义,到成年期具有临床相关性。